Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Researchers at Colorado State University used AI tools to convert conventional antibodies into intracellular “intrabodies” that light up specific histone modifications. By leveraging AlphaFold2 and ProteinMPNN, the team reduced design cycles to five candidates and achieved a 70% success rate, creating 19 functional probes, 18 of which previously failed. These fluorescent intrabodies enable continuous, real‑time imaging of gene‑expression markers inside living cells, a capability previously limited to static snapshots. The approach promises faster cancer‑research insights and new avenues for viral‑protein tracking and diagnostics.
Researchers at the University of Tokyo unveiled TECHNO, a two‑step genome‑editing platform that swaps entire mouse loci for full‑length human genes exceeding 200 kb. By combining CRISPR/Cas9‑mediated landing‑site creation with BAC‑driven integration, the method achieves high‑efficiency replacement of coding and regulatory...
We asked the biotwit some interesting industry questions. The answers were telling... 5 takeaways from last week’s biotech polls: 1️⃣ When efficacy ceilings are hit, risk wins. Safety, tolerability, and long-term risk profile now beat novelty and precision once drugs work “well enough.” 2️⃣...
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade https://t.co/VSwMpdqjqO https://t.co/DXc8P28oIZ
The JPMorgan Healthcare Conference (JPM26) highlighted a surge in biotech financing, with several firms announcing sizable funding rounds. Mirador Therapeutics disclosed a $250 million Series B raise to accelerate its gene‑therapy platform. Genentech revealed plans to bring its pharmacy‑benefit‑manager (PBM) operations in‑house,...
1/ A year into bioinformatics, your code starts to work. But that’s also when it gets dangerous. Because now you can fool yourself. https://t.co/7QCMSpI30A
$IBRX is trending on the TL - but the +40% pop more likely driven by prelim 2025 net product revenue of ~$113M, up ~700% y/y and not this tiny N CD19 CAR-NK + ritux anecdote in a rare lymphoma. https://t.co/64wkMTGX9v
The A‑Maze‑Ox is a new adjustable oxygenator designed specifically for preterm infants in neonatal intensive care units. Its micro‑fluidic membrane technology allows clinicians to fine‑tune oxygen delivery in real‑time, minimizing both hypoxia and hyperoxia. Early multicenter trials reported a 15%...
1/ Eight patients had a genetic variant. Zero controls did. That 2010 Nature paper claimed SIAE variants increased autoimmune risk 8-fold. The mouse data was clean. The functional assays checked out. https://t.co/tFKXjXEr1y
Investors should know WHAT will move a stock and WHEN, especially in biotech with the outsized moves. Build your catalyst calendar ahead of time. You won't have time to thoughtfully analyze the data when it hits #learnbiotechinvesting #biotech #investing #BiotechPrometheus https://t.co/iFc6oc4jll
Researchers applied constant‑pH molecular dynamics to the Comirnaty lipid nanoparticle formulation, uncovering a dramatic pKa shift for the ionizable aminolipid ALC‑0315. The intrinsic pKa of 9.3 in water drops to an apparent 4.9 within the LNP, with surface regions remaining...
Researchers at the National Cancer Institute have uncovered a pivotal role for tumor stem cells in oral squamous cell carcinoma, linking a specific CD44+ subpopulation to aggressive disease and treatment resistance. Using single‑cell RNA sequencing, the team identified novel stemness...
Pharma and biotech firms are accelerating SaaS adoption for drug discovery, clinical trials, and manufacturing, but fragmented identity and access management (IAM) threatens compliance and intellectual‑property protection. The life‑sciences software market hit $16.1 billion in 2024 and is growing 11‑13% annually,...
ImmunityBio announced a first‑in‑human readout of its off‑the‑shelf CD19 t‑haNK CAR‑NK therapy combined with rituximab, delivering a durable 15‑month complete response in four Waldenstrom lymphoma patients. The data propelled the stock to $5.52, up 137% from the prior week and added...
A new micro‑engineered platform dubbed the Stem Cell Gym has been shown to accelerate the maturation of human induced pluripotent stem cell‑derived cardiomyocytes. Researchers reported a 30‑40% increase in electrophysiological and contractile markers compared with conventional culture methods. The system...
Mitochondrial transfer, the movement of energy‑producing organelles between cells, is gaining prominence as a dual‑edged biological process. Healthy mitochondria can rescue stressed or damaged cells, offering therapeutic promise for neurodegenerative and cardiac diseases. Conversely, tumor cells may hijack this mechanism...
Systemic inflammation is associated with cognitive impairment. New paper suggests this relationship is caused by an acceleration of DNA methylation age https://www.tandfonline.com/doi/full/10.1080/17501911.2025.2595905
Anyone else feel that since next-gen sequencing and bioinformatics, publishing a paper in biology has become increasingly about quantity than quality?
Ildong Pharmaceutical promoted Chae Joon Lee from COO to co‑CEO while retaining his president role, and he will continue overseeing affiliates such as Yunovia, ILeadBMS, and Idience. The move signals a leadership reshuffle aimed at integrating operational expertise with strategic...
Researchers have sequenced the genome of Strobilanthes cusia and identified key genes governing indigo pigment production and stress tolerance. The study reveals specific transcription factors that boost alkaloid biosynthesis and pinpoint markers for high‑yield cultivars. Field trials using marker‑assisted selection...
SpyGlass Pharma and Agomab Therapeutics announced filings for initial public offerings on Friday, signaling a new wave of biotech listings. Both companies aim to capitalize on heightened investor enthusiasm sparked by JPMorgan's recent focus on life‑science investments. SpyGlass plans to...
During the J.P. Morgan Healthcare Conference, biotech companies attracted roughly $950 million in new capital, spread across 19 mostly private firms. The influx followed an early‑2026 surge of venture deals that pushed total private biotech funding to about $3 billion. Most of...
AbbVie and Genmab announced that their antibody‑drug conjugate Epkinly failed to extend overall survival in a Phase 3 trial for diffuse large B‑cell lymphoma (DLBCL). The study, which compared Epkinly plus standard chemotherapy against chemotherapy alone, showed no statistically significant OS...
Researchers evaluated decolorized rosemary extract as a natural antioxidant for pork, demonstrating a 30% reduction in lipid oxidation and extending refrigerated shelf life by up to five days. The decolorization process removed the herb’s green color and strong flavor, preserving...
Last year President Donald Trump urged almost all U.S. drugmakers to slash prices, but only 17 companies complied with a direct demand. The majority of manufacturers resisted, avoiding formal most‑favored‑nation (MFN) pricing agreements. Industry analysts now warn that, facing renewed...
1. Time for a #flu update. 🧵 #CDC was informed of 15 more pediatric flu deaths in the week ending 1/10, which brings this season's total to date to 32. This number, sadly, will continue to climb because kids & teens...
An international team led by Pompeu Fabra University scientists visualized the nanomachine that drives constitutive exocytosis, naming it ExHOS – a flexible ring formed by seven exocyst protein assemblies. Using combined advanced light, electron microscopy and AI‑driven image analysis, they...
USC’s Roski Eye Institute, together with Regenerative Patch Technologies, is launching a phase 2b, multicenter, masked clinical trial of a stem‑cell‑derived retinal pigment epithelium (RPE) implant for advanced dry age‑related macular degeneration (AMD). The ultra‑thin patch, derived from embryonic stem...
FDA Commissioner Marty Makary announced that the agency is overhauling its Phase 1 clinical‑trial framework to address the rapid influx of Chinese biotech firms into the U.S. market. The revision will tighten data‑integrity standards, boost early‑phase safety monitoring, and create clearer...
Patient‑centric drug development is reshaping the pharmaceutical landscape, prompting sponsors to turn to CDMOs for specialized formulation services. Advanced modalities such as peptides and RNA therapies have heightened formulation complexity, driving a surge in outsourcing to CDMOs with AI‑enabled platforms...
A new initiative at several nursing schools uses leadership-driven curricula to deepen genetics education for nursing students. Faculty mentors guide students through hands‑on genomic case studies, simulation labs, and interdisciplinary projects. Early assessments show a 22% rise in genetics competency...
Here is my favourite weekly 🧵- made by my dear friend @BiopharmIQ, which is a comprehensive recap of the past week in BioTech. This time he gathered the best posts - written by some of the brightest BioX accounts, about...
A recent study reveals that the DNA helicase MCM8 is markedly overexpressed in colorectal cancer and drives tumor progression by blocking ubiquitination pathways. By preventing the degradation of oncogenic substrates, MCM8 stabilizes proteins that promote cell proliferation and metastasis. The...
I’m often asked what the one thing to increase longevity. If it were that simple, many more people would already live to 100 Here are some tips: 1. Avoid sugar, simple carbs, alcohol 2. Lose your breath for 10 min 3x/week...
Tylenol during pregnancy is safe without increased risk of autism, ADHD, or intellectual disability of offspring A new review of the evidence just out https://t.co/Kjwp1h3PBP
In July 2025, the FDA granted approval to delgocitinib (Anzupgo®), a topical pan‑JAK inhibitor, for adult chronic hand eczema unresponsive or unsuitable for corticosteroids. Developed by Japan Tobacco and Leo Pharma, the formulation delivers the drug directly to affected skin,...
Correct. This is why we should push more of healthcare towards medicine. By far the highest leverage technology in healthcare. Consider the $5 generic antibiotic you take that saves a hospital stay. Insane savings.
Scientists have developed a #microsurgical robot that can perform #autonomous and precise retinal injections in animal models. Learn more in Science #Robotics: https://t.co/EdjxTYp5lA https://t.co/WrUZgKjYOT
The PharmTech Weekly roundup underscores a rapid shift toward agentic AI, sustainability, and resilient supply chains across drug development. The FDA and EMA released ten guiding principles for ethical AI use, while companies like Dycem, Jubilant Biosys, and SÜDPACK highlighted...
Researchers have engineered the naturally occurring vault particle into a synthetic "TimeVault" that sequesters mRNA inside the ribonucleoprotein shell, protecting it from degradation for more than a week. By fusing a major‑vault‑protein binding domain with an mRNA‑binding motif, the system...
SLAC National Accelerator Laboratory researchers have introduced a tri‑coincident system that synchronizes a scanning electron microscope, an ion‑beam mill, and an optical microscope to guide cryogenic electron tomography (cryo‑ET) sample preparation. By exploiting interference patterns in fluorescent light emitted from...
Super Agers with intact cognitive function and the frequency of the APOE-ε4 and APOE-ε2 alleles compared with controls and people with Alzheimer’s disease https://t.co/vMYcSTVCDS
Vedanta Biosciences announced a major headcount reduction, cutting roughly half of its workforce to preserve cash for a Phase III trial of its oral C. difficile candidate VE303. The layoffs follow earlier cuts after a failed Phase II study of VE202 and reflect...
GenAI has the potential to worsen health inequities. In a new review @NatureHealthJnl we show that with intent, confronting the challenges, it could be just the opposite, globally @nliulab https://t.co/jwmslSVIV1 https://t.co/5q3gq9mnez
I highly recommend attending @BiotechCH’s upcoming space today - which in my opinion is the most interesting space on 𝕏 for those interested in BioTech, Pharma, Life Sciences & everything in between….If you can’t attend it’s also available on the...
A new study reveals that microglial Fcγ receptors (FcγR) actively drive the loss of dopaminergic neurons, a hallmark of Parkinson's disease. Researchers demonstrated that FcγR activation triggers inflammatory cascades that exacerbate neuronal death in both mouse models and human post‑mortem...
ImmunityBio reported encouraging early data from its off‑the‑shelf cell‑therapy platform in a Phase 1 trial (QUILT) targeting a rare form of lymphoma. The small study demonstrated a favorable safety profile and preliminary efficacy signals, including objective responses in several patients. The...
AstraZeneca’s head of Oncology Commercial labeled its early‑stage candidate surovatamig ‘underappreciated’ during the J.P. Morgan Healthcare conference, prompting analysts to reassess the drug’s market potential. The comment followed the presentation of phase 1 data at the American Society of Hematology meeting, where...
A proposed regulatory framework would allow short synthetic DNA fragments to bypass mandatory synthesis screening, aiming to streamline research and reduce costs. The draft sets a length threshold—typically 200 base pairs—and requires labs to register exempted fragments with a central...
